Oncolytics Biotech Inc. (ONCY)
0.65
-0.01 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
0.68
3.84%
After-hours: Mar 03, 2025, 05:48 PM EST
Oncolytics Biotech Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -27.75M | -24.84M | -26.3M | -22.51M | -33.12M | -17.04M | -15.62M | -15.14M | -13.72M | -18.62M | -23.53M | -36.37M | -29.04M | -19.97M | -17M | -17.55M | -15.64M | -14.3M | -12.78M | -12.96M | -8.54M | -6.09M | -6.17M | -3.61M | -574.46K |
| Depreciation & Amortization | 403K | 392K | 452.06K | 446.19K | 485.57K | 95.38K | 90.77K | 162.23K | 180.41K | 163.5K | 131.62K | 109.28K | 92.59K | 63.16K | 257.25K | 410.25K | 1M | 926.68K | 855.99K | 751.75K | 663.52K | 574.24K | 465.45K | 205.2K | 1.68K |
| Stock-Based Compensation | 2.07M | 2.38M | 3.83M | 2.56M | 1.47M | 1.42M | 578.7K | 406.08K | 429.54K | 980.33K | 424.38K | 730.75K | 1.81M | 3.25M | 444.26K | 64.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | 1.26M | 46K | -131.59K | -1.77M | 221.34K | -862.76K | 4.95M | 1.95M | -957.16K | -2.36M | -1.31M | 1.18M | 3.56M | -1.5M | -663.81K | 1.79M | 530.3K | 789.15K | 584.76K | -69.06K | -486.17K | -1.12M | 1.77M | 376.77K | 38.43K |
| Other Non-Cash Items | -4.93M | -1.68M | 91.73K | 68.53K | 94.82K | 75.78K | -124.79K | 406.08K | 429.54K | 980.33K | 424.38K | 730.75K | 814.91K | -19.63M | 116.02K | 64.04K | 539.16K | 426.32K | 288.61K | 3.05M | 2.89M | -1 | n/a | n/a | n/a |
| Deferred Income Tax | n/a | n/a | 408.56K | -2.85M | 12.96M | -374.34K | n/a | -545.89K | -1.25M | -737.78K | -514.11K | -640.86K | n/a | 19.97M | n/a | -64.04K | n/a | n/a | n/a | n/a | n/a | -647.62K | -340.57K | -126.81K | n/a |
| Change in Working Capital | 1.76M | 391K | -907.99K | 209.78K | -1.8M | 3.9M | 180.85K | 2.23M | -1.11M | -2.44M | -1.37M | 1.19M | 3.79M | -1.72M | -642.27K | 1.79M | 530.3K | 789.15K | 584.76K | -69.06K | -486.17K | -1.12M | 1.77M | 376.77K | 38.43K |
| Operating Cash Flow | -28.45M | -23.36M | -22.43M | -22.07M | -19.91M | -11.92M | -14.89M | -12.48M | -15.03M | -19.68M | -24.44M | -34.26M | -22.54M | -18.03M | -16.82M | -15.29M | -13.57M | -12.16M | -11.05M | -9.22M | -5.48M | -7.26M | -4.27M | -3.16M | -534.35K |
| Capital Expenditures | -8K | -55K | -285.95K | -29.3K | -10.9K | -107.47K | -105.77K | -23.53K | -108.27K | -152.75K | -254.83K | -126.41K | -257.79K | -133.53K | -9.76K | -111.58K | -944.72K | -35.84K | -61.31K | -974.04K | -1.1M | -1.05M | -585.51K | -48.56K | -19.97K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.68B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -20.35M | n/a | n/a | n/a | n/a | n/a | -27.82K | -29.29K | n/a | n/a | -32.44K | n/a | -1.93M | -1.76M | -347.9K | -949.5K | -1.04M | -22.2M | -6.78M | -18.11M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 20.23M | n/a | n/a | n/a | n/a | n/a | 2.09M | n/a | n/a | n/a | n/a | n/a | 1.67M | n/a | 6.12M | 13M | 6.57M | 13.81M | 6.66M | 3.11M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -20.35K | n/a | n/a | n/a | n/a | 2.09M | -27.82 | -29.29 | -30.04K | -32.42K | -32.44 | n/a | n/a | -0.00 | 4.68B | n/a | -842.61K | -1.03M | 133.61K | 3M | -147.47K | n/a | -324.26K | -50.29K |
| Investing Cash Flow | 20.22M | -20.4M | -285.95K | -29.3K | -10.9K | -107.47K | 1.98M | -51.35K | -137.56K | -182.79K | -287.25K | -158.85K | 1.41M | -2.06M | 4.35M | 12.54M | 4.68M | 11.89M | -16.62M | -4.5M | -16.21M | -1.2M | -585.51K | -372.82K | -70.26K |
| Debt Repayment | -407K | -381K | -366K | -461K | -447.5K | n/a | n/a | n/a | 19.36M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 150K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 781K | 12K | 469.68K | 1.94M | 3.47M | 124.95K | 343.44K | n/a | -19.36M | -1.21M | 179.24K | 1.08M | 14.82M | 528.21K | 17.01M | 41.6K | n/a | n/a | 15.4M | 6.22M | 15.3M | 1.77M | n/a | 3M | 1.9M |
| Financial Cash Flow | 31.99M | 12.21M | 33.02M | 39.77M | 21.02M | 13.3M | 12.81M | 956.13K | 23.67M | 9.04M | 30.4M | 20.85M | 14.82M | 27.29M | 38.8M | 3.46M | 12.11M | 241.4K | 18.78M | 23.5M | 16M | 1.8M | 2.21M | 16.6M | 5.15M |
| Net Cash Flow | 23.25M | -29.6M | 10.04M | 17.07M | 448.14K | 1.86M | -198.16K | -11.98M | 9.86M | -11.07M | 5.9M | -13.6M | -6.38M | 6.85M | 26.2M | 714.8K | 3.22M | -19.85K | -8.9M | 9.77M | -5.68M | -6.65M | -2.65M | 13.07M | 4.55M |
| Free Cash Flow | -28.46M | -23.41M | -22.72M | -22.1M | -19.92M | -12.03M | -15M | -12.5M | -15.14M | -19.83M | -24.7M | -34.38M | -22.8M | -18.17M | -16.83M | -15.4M | -14.51M | -12.19M | -11.11M | -10.2M | -6.57M | -8.31M | -4.86M | -3.21M | -554.32K |